A study reported that there was no difference in post-prandial plasma incretin concentrations between diffuse and focal cases, and no difference in baseline plasma incretin concentration between focal, diffuse, and transient hyperinsulinism ( Studies in a mouse model of K ATP hyperinsulinism, the most common and severe genetic subtype of hyperinsulinism, have shown that the GLP-1 receptor antagonist exendin-(9-39) significantly increases fasting plasma glucose and decreases the insulin to glucose ratio on the fasting state, effectively reversing the hyperinsulinemic hypoglycemia phenotype
Many people consider making the switch after hitting a weight loss plateau, struggling with side effects, or feeling that appetite control isnt where it should be
Avicenna J
The additional potency of retatrutide may not justify the trade-offs in risk profile
Where possible, alternatives should be considered
DKD rats were treated with or without EMPA for 12 weeks (DKD + EMPA) or EMPA for first six weeks and EMPA + LINA for last six weeks (DKD + EMPA + LINA)